M-Tren
Methyltrienolone is essentially oral Trenbolone - a 17-alpha-alkylated version of Trenbolone that can be taken orally. It’s considered one of the most potent anabolic steroids ever created, with an anabolic rating of 12,000-30,000 and androgenic rating of 6,000-7,000.
The compound provides all the effects of Trenbolone - dramatic muscle hardening, fat loss, strength increases, and recomposition effects - but in oral form. However, the 17-alpha-alkylation makes it extremely hepatotoxic, far more so than injectable Trenbolone.
M-Tren is usually discussed as an ultra-potent oral for users chasing maximum effect density. In practice it is one of the worst examples of side effects scaling faster than usable benefit.
Administration: Oral compound. Most users take it with a fixed daily schedule rather than chasing short-term effect swings.
Exposure control: Keep duration conservative, because oral exposure compounds liver stress and lipid damage faster than most users expect.
Support planning: Build the rest of the cycle around the actual downside profile of this compound, not just the look or strength result it promises.
Stop or reduce if: blood pressure climbs, sleep degrades, libido crashes, or labs move sharply in the wrong direction.
Methyltrienolone is so potent that effective doses are measured in micrograms rather than milligrams, with typical doses ranging from 250-1000mcg per day. Even at these tiny doses, the compound can cause severe liver toxicity, making it one of the most dangerous oral steroids available.
The compound is primarily used by elite bodybuilders for very short periods before competitions due to its unmatched hardening and conditioning effects. It’s considered too dangerous for general use and is banned in most countries.
The core mistake is trying to prove toughness with it. Another is believing a short run removes the need for serious monitoring just because the window is brief.
Compared with virtually any mainstream oral, M-Tren is a worse cost-benefit trade unless the goal is purely novelty or experimentation.
Natural suppression with reduced fertility and testicular output
Sexual dysfunction, low libido, or nipple sensitivity if prolactin rises
Liver stress, appetite disruption, and worse lipids with oral use
Disproportionate toxicity relative to the amount of useful training progress most users get
CBC / hematocrit
blood pressure
lipid panel
ALT / AST / GGT
bilirubin
prolactin
Uncontrolled hypertension or untreated cardiovascular disease
Pre-existing severe infertility concerns unless that risk is accepted and managed
Active liver disease or already-elevated liver enzymes before starting
History of severe prolactin issues, sexual dysfunction, or intolerance to 19-nor compounds
First-cycle or low-experience use